HIMS Hims Hers Health Inc
P/E
--
Forward P/E
73.53
Price/Sales
2.636
Beta
2.432
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🔴 HIMS falls 4%, extending losses after FDA proposes new rules on compounded GLP-1 drugs
Hims & Hers Health (HIMS) is trading down ~4% to $26.17, continuing its decline following recent news of proposed regulatory changes by the U.S. Food and Drug...
Hims & Hers Faces Lawsuits Over Data Security and Privacy Failures
Hims & Hers Health faces multiple class-action lawsuits alleging data security and privacy failures. The legal actions claim the company mishandled data...
Hims & Hers Discloses Support Data Breach, Medical Records Remain Secure
Hims & Hers Health, Inc. confirmed a data breach involving a third-party customer service platform. The company detected suspicious activity on February 5,...